2023
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics
Jastreboff A, Kushner R. New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics. Annual Review Of Medicine 2023, 74: 125-139. PMID: 36706749, DOI: 10.1146/annurev-med-043021-014919.Peer-Reviewed Original ResearchConceptsGLP-1 RAsGlucagon-like peptide-1 receptor agonistsPeptide-1 receptor agonistsAnti-obesity therapeuticsTreatment of obesityMechanism-based treatmentsNeurobiology of obesityObesity treatmentReceptor agonistGLP-1Obesity therapeuticsEffective treatmentObesityHalf of AmericansFirst agentTreatmentTherapeuticsAgonistsAgents
2021
Addressing psychosocial health in the treatment and care of adolescents with obesity
Jebeile H, Cardel MI, Kyle TK, Jastreboff AM. Addressing psychosocial health in the treatment and care of adolescents with obesity. Obesity 2021, 29: 1413-1422. PMID: 34431234, DOI: 10.1002/oby.23194.Peer-Reviewed Original ResearchConceptsPsychosocial healthPsychosocial outcomesMajority of adolescentsCare of adolescentsBody imagePsychological supportPsychosocial impactObesity treatment interventionsAdolescentsTreatment interventionsSelf-directed weight lossFuture researchPsychosocial comorbiditiesReduced symptomsWeight management optionsMulticomponent interventionWeight lossFurther weight gainQuality of lifeTreatment servicesObesity treatmentImpact of interventionsInterventionAntiobesity pharmacotherapiesObesity care